Morphology of hDAF (CD55) transgenic pig kidneys following ex-vivo hemoperfusion with human blood

Transplantation

Volumn 63, Issue 2, 1997, Pages 304-310

  Storck, Martin ^a   Abendroth, Dietmar ^b   Prestel, Roland ^b   Pino Chavez, Gilda ^b   Müller Höker, Jörg ^b   White, David J G ^b   Hammer, Claus ^b  

^a UNIVERSITY OF ULM   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DECAY ACCELERATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; GRAFT REJECTION; HEMOPERFUSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; KIDNEY PERFUSION; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; SWINE; TRANSGENIC ANIMAL; TREATMENT OUTCOME; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD55; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMOPERFUSION; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; KIDNEY; KIDNEY TUBULES, PROXIMAL; MICE; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030970047     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199701270-00022     Document Type: Article

References (25)

1. Hammer C. Nature's obstacles to xenotransplantation. Transplant Rev 1994; 8: 174.
2. Sachs DH, Bach FH. Immunology of xenograft rejection. Hum Immunol 1990; 28; 245.
3. Hammer C. Isohemagglutinins and preformed natural antibodies in xenogeneic organ transplantation. Transplant Proc 1987; 19: 4443.
4. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IFC. Anti-pig IgM antibodies in human serum reacts predominantly with Gal (α1,3) epitopes. Proc Nat Acad Sci USA 1993; 90: 11391.
5. Johnston PS, Wang MW, Lim SML, Wright LJ, White DJG. Discordant xenograft rejection in an antibody free model. Transplantation 1992; 54: 573.
6. Morgan P. Complement regulatory molecules: application to therapy and transplantation. Immunol Today 1995; 16: 257.
7. White DJG, Oglesby TJ, Tedja I, et al. Human decay accelerating factor or membrane cofactor protein inhibit cross species mouse cell lysis by human complement. Transplant Int 1992; 5: 648.
8. Pruitt SK, Kirk AD, Bollinger RR, et al. The effect of soluble complement receptor typel on hyperacute rejection of porcine xenografts. Transplantation 1994; 54: 363.
9. Langford GA, Yannoutsos N, Cozzi E, et al. Production of pigs transgenic for human decay accelerating factor. Transplant Proc 1994; 26: 1400.
10. McCurry KR, Looyman DL, Alvarado CG, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med 1995; 1: 423.
11. Cozzi E, White DJG. The generation of transgenic pigs as potential organ donors for humans. Nature Med 1995; 1: 964.
12. Otte KE, Andersen N, Jorgensen KA. Xenoperfusion of pig kidneys with human AB or O whole blood. Transplant Proc 1990; 22: 1091.
13. Saumweber DM, Bergmann R, Gokel M, Hammer C. Hyperacute rejection in an ex-vivo model of renal xenografting. Transplantation 1994; 57: 358.
14. Rosengard AM, Cary NRB, Langford GA, Tucker AW, Wallwork J, White DJG. Tissue expression of human complement inhibitor, decay accelerating factor, in transgenic pigs. Transplantation 1995; 59: 1325.
15. Gianello PR, Latinne D, Alexandre GPJ. Pig-to-baboon renal xenografts. Xeno 1995; 3: 26.
16. Alvarado CG, Cotterell AH, MacCurry K, et al. Variation in the level of xenoantigen expression in porcine organs. Transplantation 1995; 59: 1589.
17. Coughlan AF, Berndt MC, Dunlop LC, Hancock. In vivo studies of P-selectin and platelet activating factor during endotoxemia, accelerated allograft rejection and discordant xenograft rejection. Transplant Proc 1993; 25: 2930.
18. Kirby JA. The role played by adhesion molecules during allograft rejection. Transplant Immunol 1994; 2: 129.
19. Inverardi L, Socci C, Pardi R. Leukocyte adhesion molecules in graft recognition and rejection. Xeno 1993; 1: 35.
20. Vilardell C, Khalil MZ, Vilella R, et al. Porcine epitopes recognized by mouse anti-human monoclonal antibodies. Transplant Proc 1995; 27: 2367.
21. Pleass HCC, Forsythe JLR, Proud G, Taylor RMR, Kirby JA. Xenotransplantation: an examination of the adhesive interactions between human lymphocytes and porcine renal epithelial cells. Transplant Immunol 1994; 2: 225.
22. Prestel R, Storck M, Pooth R, Steinbach G, Hammer C, Abendroth D. Na-K/2Cl transporter inhibition for reduction of postischemic kidney failure tested in autologous reperfusion. Transplant Int 1996; 9(suppl.1): 306.
23. Booster M, Yin M, Kurvers HAJM, et al. Inhibition of CD18-dependent leukocyte adherence by mAB 6.5 E does not prevent ischemia-reperfusion injury as seen in grafted kidneys. Transplant Int 1995; 8: 126.
24. Vercellotti GM, Platt JL, Bach FH, Dalmasso AP. Neutrophil adhesion to xenogeneic endothelium via iC3b. J Immunol 1991; 146: 730.
25. Bellgrau D, Gold D, Salwry H, Moore J, Franzusoff A, Duke RC. A role for CD 95 ligand in preventing graft rejection. Nature 1995; 377: 630.